Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32809893)

Published in J Am Heart Assoc on August 15, 2020

Authors

Ida Gregersen1,2, Annika E Michelsen1,2, Ngoc Nguyen Lunde3, Axel Åkerblom4, Tatevik G Lakic5, Mona Skjelland6, Karolina Ryeng Skagen6, Richard C Becker7, Johan Lindbäck5, Anders Himmelmann8, Rigmor Solberg3, Harald T Johansen3, Stefan K James4, Agneta Siegbahn5, Robert F Storey9, Frederic Kontny10,11, Pål Aukrust1,2,12,13, Thor Ueland1,2,13, Lars Wallentin4, Bente Halvorsen1,2

Author Affiliations

1: Research Institute for Internal Medicine Oslo University Hospital Rikshospitalet Oslo Norway.
2: Institute of Clinical Medicine Faculty of Medicine University of Oslo Norway.
3: Section of Pharmacology and Pharmaceutical Biosciences Department of Pharmacy University of Oslo Norway.
4: Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center Uppsala University Uppsala Sweden.
5: Uppsala Clinical Research Center Uppsala University Uppsala Sweden.
6: Department of Neurology Oslo University Hospital Rikshospitalet Oslo Norway.
7: Division of Cardiovascular Health and Disease Heart, Lung and Vascular Institute Academic Health Center Cincinnati OH.
8: AstraZeneca Research and Development Gothenburg Sweden.
9: Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield United Kingdom.
10: Department of Cardiology Stavanger University Hospital Stavanger Norway.
11: Drammen Heart Center Drammen Norway.
12: Section of Clinical Immunology and Infectious Diseases Oslo University Hospital Rikshospitalet Oslo Norway.
13: K.G. Jebsen TREC The Faculty of Health Sciences The Arctic University of Tromsø Tromsø Norway.

Associated clinical trials:

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome (PLATO) | NCT00391872